STAT — Reporting from the frontiers of health and medicine
- Biotech Did veteran drug developer Hal Barron accomplish his mission at GSK?
- Biotech Biotech stocks are a dumpster fire. An analyst explains what’s going on
- First Opinion Antigen testing has some serious problems. Done right, it could reshape the future of health care
- Health Tech The sale of Watson Health assets ends a dark chapter for IBM. For its buyer, the opportunity looks brighter
- First Opinion Using force crossed my mind when examining a defiant young patient. A short story made me take a breath
- Biotech Did veteran drug developer Hal Barron accomplish his mission at GSK?
- Biotech Biotech stocks are a dumpster fire. An analyst explains what’s going on
- First Opinion Antigen testing has some serious problems. Done right, it could reshape the future of health care
- Health Tech The sale of Watson Health assets ends a dark chapter for IBM. For its buyer, the opportunity looks brighter
- First Opinion Using force crossed my mind when examining a defiant young patient. A short story made me take a breath
Exclusive analysis of biotech, pharma, and the life sciences
- First Opinion Researching collagen to help his achy knees, a statistician explores the painfully weak evidence
- Health Tech Once billed as a revolution in medicine, IBM’s Watson Health is sold off in parts
- First Opinion Using force crossed my mind when examining a defiant young patient. A short story made me take a breath
-
- Pharma Building on a study of Covid drugs, scientists launch effort to accelerate clinical trials for other diseases
- Health Tech What types of mental health apps actually work? A sweeping new analysis finds the data is sparse
- Health New data show those who recovered from Covid-19 were less likely than vaccinated to get infected during Delta wave
- Health After Omicron, we could use a break. We may just get it
- In the Lab Kisses, licks, and drool: Study shows how ‘saliva sharing’ shapes babies’ understanding of the closest relationships
